Publication | Closed Access

Seralutinib in adults with pulmonary arterial hypertension (TORREY): a randomised, double-blind, placebo-controlled phase 2 trial

Placebo-controlled Phase 2HypertensionPulmonary Arterial HypertensionPulmonary CareCardiovascular DiseaseAntihypertensive TherapyCardiovascular PharmacologyPulmonary HypertensionPulmonary MedicinePharmacotherapyPublic HealthMedicinePulmonary Vascular DiseaseAnesthesiology